Homogenization of upper abdominal perfusion and multiphase enhanced CT based on artificial intelligence technology

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055456

Enrollment

Unknown

Registered

2022-01-10

Start date

2022-02-01

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver disease

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with hepatitis B, hepatitis C or alcoholic hepatitis; 2. Patients with liver cancer who have not received treatment (such as surgery, thermal ablation or chemotherapy) or patients who are suspected of hepatic space-occupying lesions by ultrasound or increased levels of tumor markers (such as alpha-fetoprotein AFP); 3. Liver fibrosis screening patients.

Exclusion criteria

Exclusion criteria: 1. Patients with tumor thrombus located in the central portal vein or hepatic vein; 2. Patients who cannot receive iodine contrast-enhanced CT scans; 3. Patients with poor cardiac function.

Design outcomes

Primary

Measure	Time frame
CT Value;	—

Countries

China

Contacts

Public ContactLi Zhenlin

HX_lizhenlin@126.com+86 18980602130

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026